COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 1 of 1 for:    NCT02810158
Previous Study | Return to List | Next Study

Mass Spectral Fingerprinting in Obstructive Sleep Apnoea

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02810158
Recruitment Status : Completed
First Posted : June 22, 2016
Last Update Posted : October 19, 2018
Swiss Federal Institute of Technology
Information provided by (Responsible Party):
University of Zurich

Brief Summary:
To answer the question whether a previously detected breath profile in patients suffering from obstructive sleep apnoea (OSA) can be found in a cohort of patients with suspected OSA using mass spectrometry (validation study).

Condition or disease
Obstructive Sleep Apnoea (OSA) Exhaled Breath Mass Spectrometry

Layout table for study information
Study Type : Observational
Actual Enrollment : 150 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Diagnosis of Obstructive Sleep Apnoea by Selective Secondary Electrospray Ionization - Mass Spectrometry (SESIMS)
Study Start Date : June 2016
Actual Primary Completion Date : May 2018
Actual Study Completion Date : May 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Sleep Apnea

Patients with suspected OSA
Persons with clinical suspicion of obstructive sleep apnoea syndrome (OSA)

Primary Outcome Measures :
  1. OSA-specific mass spectrometric pattern of VOCs in the exhaled breath [ Time Frame: one hour, single measurement, no follow-up ]
    Concentration of volatile organic compounds (VOCs) in the exhaled breath will be analysed using mass spectrometry

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 85 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients with clinical suspicion of OSA

Inclusion Criteria:

  • Clinical suspicion of obstructive sleep apnoea syndrome (based on clinical symptoms such as increased daytime sleepiness; Epworth Sleepiness Score (ESS) > 10).
  • Age between 18 and 85 years at study entry.

Exclusion Criteria:

  • None

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02810158

Layout table for location information
University Hospital Zurich, Division of Pneumology
Zurich, ZH, Switzerland, 8091
Sponsors and Collaborators
University of Zurich
Swiss Federal Institute of Technology
Layout table for investigator information
Principal Investigator: Malcolm Kohler, Prof. MD University of Zurich
Layout table for additonal information
Responsible Party: University of Zurich Identifier: NCT02810158    
Other Study ID Numbers: BASEC-Nr.2016-00384
First Posted: June 22, 2016    Key Record Dates
Last Update Posted: October 19, 2018
Last Verified: October 2018
Additional relevant MeSH terms:
Layout table for MeSH terms
Sleep Apnea Syndromes
Sleep Apnea, Obstructive
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms, Respiratory
Sleep Disorders, Intrinsic
Sleep Wake Disorders
Nervous System Diseases